# Effects of Dexmedetomidine on the Liver Injury After Hepatectomy

> **NCT02833688** · PHASE4 · COMPLETED · sponsor: **Chinese PLA General Hospital** · enrollment: 70 (actual)

## Conditions studied

- Ischemia-reperfusion Injury

## Interventions

- **DRUG:** dexmedetomidine
- **DRUG:** 0.9% sodium chloride

## Key facts

- **NCT ID:** NCT02833688
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-02
- **Primary completion:** 2017-01-26
- **Final completion:** 2017-01-26
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2017-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02833688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02833688, "Effects of Dexmedetomidine on the Liver Injury After Hepatectomy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02833688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*